
Please try another search
Investing.com - Collplant ADR reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Collplant ADR announced earnings per share of $-0.29 on revenue of $140K. Analysts polled by Investing.com anticipated EPS of $-0.28 on revenue of $3.38M.
Collplant ADR shares are up 8.69% from the beginning of the year, still down 22.26% from its 52 week high of $24.26 set on February 11. They are under-performing the Nasdaq which is up 23.91% from the start of the year.
Collplant ADR shares lost 7.40% in intra-day trade following the report.
Collplant ADR's report follows an earnings beat by Pfizer on November 2, who reported EPS of $1.34 on revenue of $24.09B, compared to forecasts EPS of $1.08 on revenue of $22.58B.
Novo Nordisk ADR had beat expectations on November 3 with third quarter EPS of $0.8209 on revenue of $5.55B, compared to forecast for EPS of $0.7768 on revenue of $5.39B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.